Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Omeprazole versus ranitidine in erosive oesophagitis.

× No keyword cloud information.

13 in total

1. Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis.

Authors: Wei-Hong Wang; Jia-Qing Huang; Ge-Fan Zheng; Harry Hua-Xiang Xia; Wai-Man Wong; Shiu-Kum Lam; Benjamin Chun-Yu Wong
Journal: World J Gastroenterol Date: 2005-07-14 Impact factor: 5.742

2. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.

Authors: M J Collen; R M Strong
Journal: Dig Dis Sci Date: 1992-06 Impact factor: 3.199

3. Omeprazole or ranitidine plus metoclopramide for patients with severe erosive oesophagitis. A cost-effectiveness analysis.

Authors: B S Bloom; A L Hillman; B LaMont; C Liss; J S Schwartz; G J Stever
Journal: Pharmacoeconomics Date: 1995-10 Impact factor: 4.981

4. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis.

Authors: H Koop; R Arnold
Journal: Dig Dis Sci Date: 1991-05 Impact factor: 3.199

Review 5. Omeprazole. Overview and opinion.

Authors: S Holt; C W Howden
Journal: Dig Dis Sci Date: 1991-04 Impact factor: 3.199

6. Mesalazine release from a pH dependent formulation: effects of omeprazole and lactulose co-administration.

Authors: F N Hussain; R A Ajjan; M Moustafa; N W Weir; S A Riley
Journal: Br J Clin Pharmacol Date: 1998-08 Impact factor: 4.335

Review 7. A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.

Authors: N Sharma; C Donnellan; C Preston; B Delaney; G Duckett; P Moayyedi
Journal: Gut Date: 2004-05 Impact factor: 23.059

Review 8. Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors: S M Grant; H D Langtry; R N Brogden
Journal: Drugs Date: 1989-06 Impact factor: 9.546

Review 9. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.

Authors: N J Bell; R H Hunt
Journal: Gut Date: 1992-01 Impact factor: 23.059

10. Comparative tolerability profile of omeprazole in clinical trials.

Authors: T J Simon; D C Bradstreet
Journal: Dig Dis Sci Date: 1991-10 Impact factor: 3.199